drugset / Trial / NCT03542279
CPI Combination Therapy for Autoimmune Encephalitis
RandomizedSingle-groupSingle-blindTreatment
Summary
Corticosteroids, intravenous immunoglobulin (IVIG), and plasma exchange (PE) are the first-line therapies for autoimmune encephalitis (AE) patients, but optimal first-line treatment strategy for different AE patients remains undetermined. The study is to compare the efficacy between pulse corticosteroid plus PE initially followed by IVIG (CPI therapy) and pulse corticosteroid plus IVIG followed by PE two weeks later (CIP therapy) in patients with severe antibody-associated autoimmune encephalitis (AE).
Timeline
- Start
- 2020-11-25
- Primary completion
- 2022-12-12
- Completion
- 2024-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 500 mg | Intravenous |
| Subject | Methylprednisolone | Other / unclassified | 1000 mg | Intravenous |
| Subject | intravenous immunmoglobulin | Protein / enzyme biologic | 0.4 g/kg | Intravenous |